Lupus anticoagulants in patients with systemic lupus erythematosus

Ryumachi

Volumn 36, Issue 1, 1996, Pages 16-24

  Matsuura, Y ^a   Nawata, Y ^a   Miike, S ^a   Hiraguri, M ^a   Kita, Y ^a   Kurasawa, K ^a   Takabayashi, K ^a   Oh, H ^a   Iwamoto Saito, I Y ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

2 glycoprotein I; anti phospholipid antibody syndrome (APS); anticardiolipin antibody; lupus anticoagulant; systemic lupus erythematosus (SLE)

Indexed keywords

ANTITHROMBIN III; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; KAOLIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; THROMBOMODULIN; VIPER VENOM;

ABORTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOTTING TIME; CONTROLLED STUDY; HEMOLYTIC ANEMIA; HUMAN; MAJOR CLINICAL STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE ADHESIVENESS; THROMBOCYTE AGGREGATION; THROMBOSIS;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; BLOOD COAGULATION TESTS; FEMALE; HUMANS; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PLATELET ADHESIVENESS; PLATELET AGGREGATION;

EID: 0029942965     PISSN: 03009157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)